These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1123 related articles for article (PubMed ID: 6951050)

  • 1. Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors.
    Cordiali-Fei P; Natali PG; Pecci G; Pellegrino MA; Ferrone S
    J Clin Lab Immunol; 1981 Nov; 6(3):197-9. PubMed ID: 6951050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
    García MS; Barañao RI; Fernández O; Rumi LS
    Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncofetal antigen-I: distribution in human tumors.
    Rees WV; Irie RF; Morton DL
    J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Ia-like antigens (Analysis of the tissue distribution and immunochemical profile with monoclonal antibodies).
    Natali PG; Russo C; Apollonj C; Pellegrino MA; Ferrone S
    Ric Clin Lab; 1981; 11(4):287-300. PubMed ID: 7034133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients.
    Kaszubowski PA; Husby G; Tung KS; Williams RC
    Cancer Res; 1980 Dec; 40(12):4648-57. PubMed ID: 6969113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey.
    Washington K; McDonagh D
    Mod Pathol; 1995 May; 8(4):427-33. PubMed ID: 7567944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
    Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
    Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of migration inhibition techniques in tumor immunology.
    Szigeti R
    Adv Cancer Res; 1985; 43():241-305. PubMed ID: 2986429
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M; Köhler G
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of preclinical and differential diagnosis of malignant neoformations according to the percentage of large granular lymphocytes].
    Kindzel'skiĭ LP; Zlochevskaia LL; Shabaeva MM; Tolstopiatov BA; Zhukova VM; Rudaia OI; Vinnitskaia AB
    Vopr Onkol; 1989; 35(12):1441-3. PubMed ID: 2609539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of the serum immunoglobulins in cases of malignant neoplasms].
    Fagiolo E; Sanso G
    Riv Anat Patol Oncol; 1967 Mar; 31(3):331-44. PubMed ID: 4178363
    [No Abstract]   [Full Text] [Related]  

  • 14. HL-A antigens in solid tumors.
    Takasugi M; Terasaki PI; Henderson B; Mickey MR; Menck H; Thompson RW
    Cancer Res; 1973 Apr; 33(4):648-50. PubMed ID: 4739655
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 16. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
    Zhukhina GE
    Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of peripheral lymphocytes in patients with solid malignant tumors].
    Rumi LS; Eugui EM; Balbiani RL; Barañao RI
    Medicina (B Aires); 1981; 41(2):132-6. PubMed ID: 7278611
    [No Abstract]   [Full Text] [Related]  

  • 18. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
    Vincent-Salomon A; Jouve M; Genin P; Fréneaux P; Sigal-Zafrani B; Caly M; Beuzeboc P; Pouillart P; Sastre-Garau X
    Cancer; 2002 Apr; 94(8):2169-73. PubMed ID: 12001113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thomsen antigen in human normal and tumor tissues].
    Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
    Biull Eksp Biol Med; 1983 Mar; 95(3):59-61. PubMed ID: 6830988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.